Delivery Order SPE2DR25D2006-SPE2DR26F55ZF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Ketorolac 30 mg/mL in vial form, with a ceiling value of $1,126.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 3, 2025, for the supply of Ketorolac 60mg/2ml in quantities of 25 units. This firm fixed-price delivery order, valued at $8,163.57, represents a non-competitive award and is scheduled for completion by December 2, 2025. The contract will be performed at AmerisourceBergen's Conshohocken facility and supports the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 6, 2025, for the supply of Ketorolac 30 mg/mL vials. The contract carries a ceiling value of $2,143.55 with firm fixed pricing and an ultimate completion date of November 7, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in...
- The Defense Logistics Agency awarded a $1,086.88 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials under a firm fixed price contract type. The award was issued on July 11, 2025, with an ultimate completion date of July 14, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.80 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials. This competitive, firm fixed-price delivery order was issued on October 16, 2025, with an ultimate completion date of October 17, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $10,570.63 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This competitively awarded, firm fixed-price contract is scheduled for completion by September 19, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,002.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency Medical Supply Chain awarded a $7,301.66 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials, with an ultimate completion date of August 13, 2025. This competitive award represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Ketorolac 30 mg/mL vials with a ceiling value of $2,472.26. This firm fixed-price delivery order represents a non-competitive set-aside contract and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a $10,033.32 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30mg/ml (25 units) on November 7, 2025, with an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F55ZFDelivery Order
The Defense Logistics Agency awarded a $1,597.07 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vials on November 9, 2025, with completion scheduled for November 10, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains significant federal procurement relationships with the Defense Logistics Agency and Defense Health Agency. The company's extensive contract portfolio demonstrates its capacity to supply diverse pharmaceutical products including specialty medications, generic drugs, vaccines, and medical devices across multiple therapeutic domains. This ketorolac delivery order reflects AmerisourceBergen's continued role as a critical vendor supporting federal medical supply chain requirements through competitive federal contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 11/9/25 |